Anti-KRT17 Antibody

Supplied by Antibodies.com as a ready-to-use polyclonal reagent, this antibody targets cytokeratin 17 (KRT17), a type I cytoskeletal intermediate filament protein also referred to as Keratin-17, K17, CK-17, or Cytokeratin-17. It is raised in rabbit and purified by affinity chromatography against an immunogen consisting of recombinant human KRT17 protein, enabling specific detection of the endogenous total KRT17 pool in lysates and fixed specimens. The 50 µL vial is provided at a concentration of 1.0 mg/mL in phosphate-buffered saline (pH 7.4, without Mg²⁺ and Ca²⁺) containing 150 mM NaCl, 0.02% sodium azide, and 50% glycerol as a cryoprotectant; the product is unconjugated, allowing downstream labelling flexibility for Western blot (WB) and immunocytochemistry/immunofluorescence (ICC/IF) workflows. Validated reactivity spans human, mouse, and rat samples, supporting broad translational coverage. Shipping is performed at 4 °C, and for long-term stability aliquots should be stored at −20 °C while avoiding repeated freeze/thaw cycles. For research use only, the antibody is intended as a primary detection tool, not for diagnostic or therapeutic purposes. The combination of polyclonal coverage, an unconjugated format, and verified performance across WB and ICC/IF makes this Antibodies.com reagent a versatile choice for studies of epithelial differentiation, wound healing, and tumour biology where KRT17 expression patterns are of interest.